According to Ipca Laboratories
's latest financial reports the company has $0.12 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $0.26 B | 47.86% |
2022-03-31 | $0.17 B | 73.7% |
2021-03-31 | $0.10 B | 86.14% |
2020-03-31 | $55.41 M | 3.56% |
2019-03-31 | $53.51 M | 59.36% |
2018-03-31 | $33.58 M | 47.02% |
2017-03-31 | $22.84 M | -12.81% |
2016-03-31 | $26.19 M | 12.89% |
2015-03-31 | $23.2 M | 86.65% |
2014-03-31 | $12.43 M | 18.5% |
2013-03-31 | $10.49 M | 384.76% |
2012-03-31 | $2.16 M | -8.13% |
2011-03-31 | $2.35 M | -92.28% |
2010-03-31 | $30.51 M | 64.99% |
2009-03-31 | $18.49 M | -5.89% |
2008-03-31 | $19.65 M | 74.08% |
2007-03-31 | $11.28 M | 817.31% |
2006-03-31 | $1.23 M | 6.95% |
2005-03-31 | $1.15 M |